Skip to main content
Niramai logo

Niramai

Updated Mar 24, 2026

How Niramai stacks up in AI Healthcare — funding data, key investors, and more.

🇮🇳IndiaSeries BAI Healthcare

Out of 100

🇮🇳

HQ

India

🗓

Founded

2016

💰

Raised

$17M

🏷️

Stage

Series B

👥

Team

50-200

Niramai has developed a radiation-free, non-contact breast cancer screening solution that uses thermal imaging combined with AI-powered image analysis to detect early-stage breast cancer, addressing the significant access and cost barriers that prevent widespread mammography screening in low- and middle-income countries. The technology works without X-ray radiation, requires no radiologist for

Is this your company? Claim it →

Key Facts

  • Niramai has raised a total of $17M in disclosed funding across 3 funding rounds.
  • Niramai was founded in 2016 by Geetha Manjunath and is headquartered in India.
  • Niramai employs approximately 50-200 people.
  • Niramai operates in the AI Healthcare category and is currently at the Series B stage.
  • Niramai has an Awaira Score of 60/100, ranking it among the tracked AI companies on Awaira.
  • Niramai's most recent funding round was a Series B of $11.9M closed in February 2019.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$17M

All rounds

60/100

2016

50-200 employees

Strengths

Strong Awaira Score of 60/100

Large team of 50-200+ employees

Part of India's rapidly growing AI ecosystem

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

3

Total Rounds

$5.67M

Avg Round Size

2.7yr

Funding Span

Niramai raised 3 rounds over 2.7 years, averaging $5.67M per round — a pace of roughly one round every 11 months.

⚠️ ESTIMATE
💵Est. Annual Revenue
$5M–$20M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Niramai stack up against competitors?

MetricNiramaiButterfly NetworkTempusAlan
Awaira Score60/10085/10084/10083/100
Total Raised$17M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageSeries BPublicPublicSeries D
Founded2016201120152016
Employees50-200500-10002500500-1000
Country🇮🇳🇺🇸🇺🇸🇫🇷
G

Geetha Manjunath

Founder & CEO

View founder profile →
StageSeries B
Employees50-200
Country🇮🇳 India
Connect
Inactive
3 rounds
Series BLatest

$11.9M

Feb 2019

Series A

$3.74M

Oct 2017

Seed

$1.36M

Jun 2016

Frequently Asked Questions

What is Niramai's valuation?
Valuation data is currently unavailable. The company may disclose this figure when it announces its next funding round.
Who invested in Niramai?
The investor base hasn't been publicly disclosed. The company may have institutional or angel backers that remain unnamed.
When did Niramai last raise funding?
The most recent round was a Series B of $11.9M, closed in February 2019.
How many employees does Niramai have?
The team is roughly 50-200 people, headquartered in India.
What does Niramai do?
Niramai has developed a radiation-free, non-contact breast cancer screening solution that uses thermal imaging combined with AI-powered image analysis to detect early-stage breast cancer, addressing the significant access and cost barriers that prevent widespread mammography screening in low- and middle-income countries. The technology works without X-ray radiation, requires no radiologist for initial interpretation, and can be deployed in mobile screening units. The company operates in the AI Healthcare sector from India.
Who founded Niramai?
The company was started by Geetha Manjunath in 2016 in India. Geetha Manjunath serves as Founder & CEO.
Is Niramai profitable?
Whether the company is profitable hasn't been confirmed publicly. It has raised $17M in total funding and is classified at the Series B stage.
Where is Niramai headquartered?
Home base is India 🇮🇳. The AI Healthcare company was founded in 2016 and operates from there.
⚔️

Compare Niramai

See how Niramai stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →